Patent ID: 8088811
Filing Date: 2012-01-03
Classification: A61P,C07D

Abstract:
1. A method of treating benign prostatic hyperplasia comprising administering to a subject in need thereof a therapeutically effective amount of the compound of Formula I wherein W is selected from the group consisting of O, S and NR wherein R R R a is an integer from 0 to 1; is pyridyl; R R R provided that R provided further that R 4 is absent when a nitrogen atom is present at the 4-position of provided further that R 6 is absent when a nitrogen atom is present at the 6-position of provided further that R 7 is absent when a nitrogen atom is present at the 2-position of is selected from the group consisting of wherein R R wherein the aryl, cycloalkyl, heteroaryl or heterocycloalkyl, whether alone or as part of a substituent group is optionally substituted with one or more substituents independently selected from the group consisting of halogen, hydroxy, C or a pharmaceutically acceptable salt thereof.